Weight loss and improvement of lipid profiles in morbidly obese patients after laparoscopic one-anastomosis gastric bypass: 2-year follow-up

被引:0
作者
Miguel A. Carbajo
Arlett Fong-Hirales
Enrique Luque-de-León
Juan Francisco Molina-Lopez
Javier Ortiz-de-Solórzano
机构
[1] Centro de Excelencia para el Estudio y Tratamiento de la Obesidad y la Diabetes,
[2] Instituto Nacional de Ciencias Medicas y de Nutrición Salvador Zubirán,undefined
来源
Surgical Endoscopy | 2017年 / 31卷
关键词
Dyslipidemia; One-anastomosis gastric bypass; Morbid obesity; Mini-gastric bypass; Bariatric surgery; Hypertriglyceridemia; Hypercholesterolemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:416 / 421
页数:5
相关论文
共 116 条
[1]  
Mokdad AH(2001)The continuing epidemics of obesity and diabetes in the United States JAMA 286 1195-1200
[2]  
Bowman BA(2009)The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis BMC Public Health 9 88-1576
[3]  
Ford ES(2009)The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk actors PLoS Med 6 e1000058-404
[4]  
Vinicor F(2012)Bariatric surgery versus intensive medical therapy in obese patients with diabetes N Engl J Med 366 1567-280
[5]  
Marks JS(2005)One anastomosis gastric bypass by laparoscopy: results of the first 209 patients Obes Surg 15 398-1038
[6]  
Koplan JP(2001)The mini-gastric bypass: experience with the first 1274 cases Obes Surg 11 276-940
[7]  
Guh DP(2014)Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the european accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass Nutr Hosp 30 1032-179
[8]  
Zhang W(2016)Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve gastrectomy at 1 year of follow-up. A European survey Obes Surg 26 933-453
[9]  
Bansback N(2003)The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat Diabetes 52 172-828
[10]  
Amarsi Z(2002)Obesity and cardiovascular disease Curr Atheroscler Rep 4 448-616